These bipolar devices offer clinical, economic and practical advantages over other devices. If UPP can be performed with existing monopolar instruments, what would prompt surgeons to choose these particular bipolar instruments instead? The answer to that question is as follows:
At this time the FDA approval process has not begun. It is anticipated that a 510(k) clearance, as opposed to a Premarket Approval ("PMA"), would only be necessary for the devices that are "substantially similar" to "predicate devices." Further, since the devices rely on known electrosurgical principles and operate utilizing approved electrosurgical generators, a strong argument exists that the devices present a "non-significant risk" to patients when compared to existing monopolar devices. See the Discussion of FDA Process.
The low-cost suite of bipolar electrosurgical devices for performing UPP are designed to be compatible with the generator units of most manufacturers. Moreover, licensing of the above will provide your company with a proprietary line of hand pieces to enhance its product line, whether it manufactures and distributes or merely distributes generators and/or handpieces. Licensing of the methodology provides opportunities for other creative marketing programs. We hope that you will find that these devices will allow your company to uniquely position itself to offer an inexpensive answer to medical practitioners in treating the large numbers of habitual snorers in an expanding market.
We are interested in entering into an exclusive licensing agreement with your company (or an assignment of rights to the patent applications) in return for a royalty (with a minimum amount per year) to permit final product development, to allow the submission of the appropriate FDA applications, to conduct clinical trials and to manufacture, distribute and sell the devices described in this disclosure as well as licensing of the methodology.